- List
- By Topic
- On Map
- Search Details

"osteoporosis-pseudoglioma syndrome" OR "juvenile osteoporosis"
Need help? See RSS Feeds
Choose a feed type:

"osteoporosis-pseudoglioma syndrome" OR "juvenile osteoporosis" (8 records)
Need help? See Downloading Content for Analysis
For Advanced Users: Full Study Record XML Download
1 | NCT01614171 | Withdrawn | Growth Hormone for Osteoporosis Pseudoglioma Syndrome |
|
|
Interventional | Not Applicable |
|
Other |
|
|
0 | All | 4 Years and older (Child, Adult, Senior) | NCT01614171 | HP-00053014 | GHOPPG | December 2013 | December 2015 | December 2015 | June 7, 2012 | April 21, 2017 |
|
|
2 | NCT01108068 | Completed | Trial of Lithium Carbonate for Treatment of Osteoporosis-pseudoglioma Syndrome |
|
|
Interventional | Not Applicable |
|
Other |
|
|
5 | All | 4 Years to 64 Years (Child, Adult) | NCT01108068 | HP-40536 | July 2010 | July 2014 | July 2014 | April 21, 2010 | December 2, 2015 |
|
||
3 | NCT00920075 | Completed Has Results |
Alendronate in Juvenile Osteoporosis |
|
|
Observational |
|
Other / U.S. Fed / Industry |
|
11 | All | 8 Years to 21 Years (Child, Adult) | NCT00920075 | 5R01FD001847-05 REVISED FD-R-001847-03 5R01FD001847-05 |
July 2009 | September 2009 | October 2010 | June 15, 2009 | December 10, 2010 | December 10, 2010 |
|
|||
4 | NCT00757393 | Unknown † | Growth Hormone Therapy and Bone Quality in Pediatric Osteoporosis |
|
|
Interventional | Phase 3 |
|
Other |
|
|
28 | All | 5 Years to 16 Years (Child) | NCT00757393 | 1000012269 | September 2008 | September 2015 | September 2015 | September 23, 2008 | September 9, 2013 |
|
||
5 | NCT00010439 | Completed Has Results |
Phase II Study of Alendronate Sodium in Children With High-Turnover Idiopathic Juvenile Osteoporosis |
|
|
Interventional | Phase 2 |
|
Other / Industry |
|
|
10 | All | 5 Years to 14 Years (Child) | NCT00010439 | 199/15705 FD-R-001847-01 |
September 2000 | October 2003 | November 2008 | February 2, 2001 | November 8, 2010 | September 17, 2010 |
|
|
6 | NCT00001720 | Completed | Treatment of Childhood Osteoporosis With Alendronate (Fosamax) |
|
|
Interventional | Phase 2 |
|
NIH |
|
50 | All | Child, Adult, Senior | NCT00001720 | 980077 98-CH-0077 |
March 1998 | June 2003 | November 4, 1999 | September 22, 2016 |
|
||||
7 | NCT00259857 | Completed Has Results |
Safety and Efficacy of Alendronate (Fosamax) in Children With Osteoporosis |
|
|
Interventional | Phase 2 |
|
Other / U.S. Fed / Industry |
|
|
22 | All | 5 Years to 15 Years (Child) | NCT00259857 | 5R01FD001847-05 FDR00184705-83045-05 |
October 2003 | March 2008 | August 2009 | December 1, 2005 | January 19, 2011 | January 19, 2011 |
|
|
8 | NCT00655681 | Completed | Prevention of Post Operative Bone Loss in Children |
|
|
Interventional | Not Applicable |
|
Other |
|
|
24 | All | 4 Years to 18 Years (Child, Adult) | NCT00655681 | 07-213 | September 2007 | August 2011 | August 2011 | April 10, 2008 | March 1, 2012 |
|
† Study has passed its completion date and status has not been verified in more than two years.